A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.
| Image |  |
|---|---|
| Description | scientific article published on September 2006 |
| Author/s | |
| Publication date | September 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |